版本:
中国

BRIEF-Argos Reports interim results of the ADAPT trial

April 18 Argos Therapeutics Inc:

* Argos reports interim results of the ADAPT trial and provides perspective on decision to continue the trial

* Argos Therapeutics Inc- continues to analyze data from trial and plans to meet with fda in may 2017

* Argos Therapeutics Inc- currently believes based on data it has reviewed that trial should be continued until completion Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐